@article {Arevalo19001875, author = {Philip Arevalo and Huong Q. McLean and Edward A. Belongia and Sarah Cobey}, title = {Earliest infections predict the age distribution of seasonal influenza A cases}, elocation-id = {19001875}, year = {2019}, doi = {10.1101/19001875}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Seasonal variation in the age distribution of influenza A cases suggests that factors other than age shape susceptibility to infection. We ask whether these differences can be explained in part by protection conferred by childhood influenza infection, which has lasting impacts on immune responses to influenza and protection against novel influenza A subtypes (phenomena known as original antigenic sin and immune imprinting). Fitting a statistical model to data from studies of influenza vaccine effectiveness (VE), we find that primary infection appears to reduce the risk of medically attended infection with that subtype throughout life. This effect is stronger for H1N1 compared to H3N2. Additionally, we find evidence that influenza VE varies with both age and birth year, but not with the imprinting subtype, indicating that VE may be sensitive to particular exposure histories. The ability to predict age-specific risk might improve forecasting models and vaccination strategies to combat seasonal influenza.Competing Interest StatementThe authors report grants from National Institutes of Health during the conduct of the study. HQM receives research support from Seqirus unrelated to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Funding StatementFunding for this project was provided by the National Institutes of Health (NIH), Department of Health and Human Services, under grant DP2AI117921 (to SC) and CEIRS Contract No. HHSN272201400005C (to SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesData for this study are available at www.github.com/cobeylab/FluAImprinting https://github.com/cobeylab/FluAImprinting}, URL = {https://www.medrxiv.org/content/early/2019/09/08/19001875}, eprint = {https://www.medrxiv.org/content/early/2019/09/08/19001875.full.pdf}, journal = {medRxiv} }